[China Experts Consensus on Icotinib for Non-small Cell Lung Cancer Treatment (2016 version)]

Affiliations

• ¹ National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Beijing 100021, China.
• ² The Fourth Hospital of Hebei Medical University, Shijiazhuang 050000, China.
• ³ Beijing Cancer Hospital, Beijing 100142, China.
• ⁴ Tianjin Medical University Cancer Institute and Hospital, Tianjin 300070, China.
• ⁵ The Second Military Medical University Changhai Hospital, Shanghai 200433, China.
• ⁶ Fudan University Zhongshan Hospital, Shanghai 200032, China.
• ⁷ Jiangsu Cancer Hospital, Nanjing 210009, China.
• ⁸ The 307th Hospital of Chinese People's Liberation Army, Beijing 100071, China.
• ⁹ Chinese People's Liberation Army General Hospital, Beijing 100853, China.
• ¹⁰ Jiangsu Province Hospital, Nanjing 210029, China.
• ¹¹ Qinghai University Affiliated Hospital, Xining 810000, China.
• ¹² The First Affiliated Hospital of Guangzhou Medical Unversity, Guangzhou 510000, China.
• ¹³ Zhejiang Cancer Hospital, Hangzhou 310022, China.
• ¹⁴ Beijing Chest Hospital, Capital Medical University, Beijing 101149, China.
• ¹⁵ Harbin Medical University Cancer Hospital, Harbin 150081, China.
• ¹⁶ The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
• ¹⁷ Nanfang Medical University Nanfang Hospital, Guangzhou 510515, China.
• ¹⁸ Tongji University Affiliated Shanghai Pulmonary Hospital, Shanghai 200433, China.
• ¹⁹ The First Affiliated Hospital, Zhejiang University, Hangzhou 310003, China.
• ²⁰ Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200030, China.
• ²¹ Changzhou Fourth People's Hospital, Changzhou 213001, China.
• ²² Fujian Cancer Hospital, Fuzhou 350014, China.